We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

DNA-based Microarray Identifies Dynamic Microbes

By LabMedica International staff writers
Posted on 13 Oct 2011
Two methods that are independent of polymerase chain reactions (PCRs) have been developed to identify microbial communities. More...


The methods use a high-density microarray with direct hybridization of 16S rRNA (dirRNA) or ribosomal RNA (rRNA) converted to double-stranded complementary DNA (dscDNA).

Scientist from Lawrence Berkeley [US] National Laboratory (Berkeley, CA, USA) identified the individual microbial taxa in a sample via the genetic signatures of the rRNA, which is the genetic component of the ribosome, the machinery within a biological cell that makes proteins. They used one archaeal and seven bacterial cultures grown to a cell density of approximately 108 to 109 cells/mL overnight. The microbes were detected using is a square-shaped microarray chip, with a dimension of approximately 25 mm and called the PhyloChip. The latest version is packed with more than a million individual probes and can be used to detect quickly, accurately, and comprehensively the presence of up to 50,000 different species of bacteria and archaea in a single sample from any environmental source, without the need of culturing.

One drawback to this method is that RNA binds much more tightly to the PhyloChip probes than is typical for DNA. This results in increased background noise and variability that can pose challenges. In response, the scientists developed a second PCR-free method in which the rRNA is replaced with a complementary DNA sequence (cDNA). The cDNA complement is then synthesized to create a double-stranded cDNA fragment that closely mirrors the properties of a PCR amplified 16S rRNA gene fragment. The PhyloChip is manufactured by Affymetrix Corp. (Santa Clara, CA, USA).

Gary Andersen, PhD, a microbial ecologist with Berkeley National Laboratory and senior author of the study, said, “Each method represents a simple and economical way to directly query microbial communities in natural environments and each offers the additional advantage of detecting the most metabolically active microbes in a community, the ones most likely to attenuate toxins, drive biogeochemical cycles, or proliferate in disease states.”

The study was published in the September 2011 edition of the journal Applied and Environmental Microbiology.

Related Links:

Lawrence Berkeley National Laboratory
Affymetrix





Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.